Marco Angelillis Selected Research

CI 600

9/2020

Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Angelillis Research Topics

Disease

6	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 01/2017
2	Myocardial Infarction 01/2020 - 11/2017
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Chronic Renal Insufficiency 12/2020
1	Frailty 09/2020
1	Ventricular Remodeling 09/2020
1	Bicuspid Aortic Valve Disease 09/2020
1	Thrombosis (Thrombus) 01/2020
1	Cardiogenic Shock 01/2020
1	Kidney Neoplasms (Kidney Cancer) 04/2019
1	Left Ventricular Dysfunction 11/2017
1	Heart Failure 11/2013
1	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2013

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 09/2020 - 11/2013
1	CalciumIBA 01/2021
1	CI 600IBA 09/2020
1	CytokinesIBA 09/2020
1	Growth Differentiation Factor 15IBA 09/2020
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2013
1	Furosemide (Lasix)FDA LinkGeneric 11/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2013
1	pro-brain natriuretic peptide (1-76)IBA 11/2013

Therapy/Procedure

5	Transcatheter Aortic Valve Replacement 01/2021 - 01/2017
1	Therapeutics 01/2021
1	Resuscitation 01/2020
1	Stents 01/2020
1	Cannula 04/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2017
1	Percutaneous Coronary Intervention 11/2017